Trusted Resources: Education
Scientific literature and patient education texts
Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis: Progress and Hope
source: Revista Española de Cardiología
year: 2017
authors: González-López E, López-Sainz Á, Garcia-Pavia P
summary/abstract:Cardiac amyloidosis is an infiltrative disorder caused by extracellular protein deposition. Transthyretin is a proamyloidotic protein that produces one of the most frequent forms of cardiac amyloidosis, either through mutations or a wild-type form (previously known as senile amyloidosis). Until very recently, diagnosis of transthyretin amyloidosis (ATTR) was very uncommon and histological confirmation was mandatory, making diagnosis of ATTR a real challenge in daily clinical practice. Moreover, the specific therapeutic options to alter the clinical course of the disease were very limited. However, advances in cardiac imaging and diagnostic strategies have improved recognition of ATTR.
In addition, several compounds able to modify the natural history of the disease are in the final phases of research, with promising results. Given that effective therapies are on the horizon, cardiologists should be well-versed in this disease and be familiar with its diagnosis and treatment. This review describes the broad clinical spectrum of ATTR in detail, as well as recent advances in the diagnosis and treatment of this condition.
organization: Hospital Universitario Puerta de Hierro, Spain; Universidad Francisco de Vitoria, SpainDOI: 10.1016/j.rec.2017.05.036
read more full text
Related Content
-
Webinar Presentation by Mat Maurer on Cardiac Amyloidosishttps://www.youtube.com/watch?v=SVOfge65...
-
Symptom Management in Amyloid Neuropathy – ASG Webinar 8/11https://www.youtube.com/watch?v=K2TmwAfu...
-
Familial Amyloidosis: What Does it Mean for Your Family?http://amyloidosissupport.org/support_gr...
-
Amyloidosis now a hot topic in cardiac imaging due to new drug treatmentJuly 11, 2023 | Cardiovascular Business ...
-
Melissa Lyle: Cardiac Amyloidosis: Heart Failure Symptoms and Treatment – ASG Webinar 1.25.24 – 2/9https://www.youtube.com/watch?v=A9g6r1PQ...
-
The Coverage Battle Continues for Veterans With Transthyretin AmyloidosisThe Veterans Health Administration exist...
-
Familial Amyloidosis: Great Progress for an Orphan DiseaseFamilial amyloidosis (synonym for famili...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.